Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study.
about
Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Inhaled indacaterol for the tr ...... the randomized INFINITY study.
@ast
Inhaled indacaterol for the tr ...... the randomized INFINITY study.
@en
type
label
Inhaled indacaterol for the tr ...... the randomized INFINITY study.
@ast
Inhaled indacaterol for the tr ...... the randomized INFINITY study.
@en
prefLabel
Inhaled indacaterol for the tr ...... the randomized INFINITY study.
@ast
Inhaled indacaterol for the tr ...... the randomized INFINITY study.
@en
P2093
P2860
P356
P1476
Inhaled indacaterol for the tr ...... the randomized INFINITY study.
@en
P2093
Cheong-Ju Kim
Chul-Gyu Yoo
Hyoung-Kyu Yoon
Jae Jeong Shim
Jeong-Woong Park
Ki-Suck Jung
Kwang-Ha Yoo
Myung-Jae Park
Seong Yong Lim
P2860
P304
P356
10.2147/COPD.S128750
P407
P50
P577
2017-05-29T00:00:00Z